Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study

BACKGROUND: Early diagnosis and treatment of esophageal squamous cell dysplasia (ESCdys) and esophageal squamous cell carcinoma (ESCC) could significantly reduce the incidence and mortality of ESCC. This pilot study aimed to investigate whether P16/CDKN2A methylation could serve as a cytologic bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhiyuan, Qin, Yu, Zhou, Jing, Chen, Ru, Gu, Jianhua, Li, Minjuan, Zhou, Jiachen, Li, Xinqing, Lin, Dongmei, Wang, Jinwu, Deng, Dajun, Wei, Wenqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636512/
https://www.ncbi.nlm.nih.gov/pubmed/35352503
http://dx.doi.org/10.1002/cam4.4718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636512/
https://www.ncbi.nlm.nih.gov/pubmed/35352503
http://dx.doi.org/10.1002/cam4.4718

Ejemplares similares